Alembic Limited (NSE:ALEMBICLTD)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Active Pharmaceutical Ingredient (API)	465.85M	322.15M	317.42M	264.88M	322.66M
Real Estate	1.93B	1.90B	1.26B	1.01B	459.51M
Total	2.40B	2.22B	1.57B	1.27B	782.18M

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	151.94M	74.38M	71.19M	84.98M	119.69M
Exports	12.30M	25.03M	37.02M	16.80M	17.37M
Unallocated	2.24B	2.12B	1.47B	1.17B	645.11M
Total	2.40B	2.22B	1.57B	1.27B	782.18M

Data Source: S&P Global Market Intelligence Last updated: Nov 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error